Inhibition of choroidal melanoma by interferon alpha 2b (IFNα2b)

被引：0
|
作者：
Neale, M [1 ]
Myatt, N [1 ]
Hungerford, JL [1 ]
Plowman, PN [1 ]
Cree, IA [1 ]
机构：
[1] UCL, Inst Ophthalmol, Dept Pathol, London EC1V 9EL, England
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
335
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Intermediate dose interferon alpha 2b (IFN alpha 2b) in adiuvant treatment for Malignant Melanoma
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, A.
    Pepe, A.
    Blasi, L.
    Usset, A.
    Rondello, G.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2005, 16 : 171 - 171
  • [2] Role of interferon alpha 2b (IFN-α2b) in the treatment of conjunctive squamous neoplasia
    Diaz, Maria Dolores
    Boned, Ana
    del Buey, Maria Angeles
    Marco, Sara
    Lopez, Isabel
    Karlsruher, Gisela
    Montes, Paula
    Ascaso, Francisco Javier
    ACTA OPHTHALMOLOGICA, 2019, 97
  • [3] INTERMEDIATE DOSE INTERFERON ALFA 2B (IFN ALFA 2B) IN ADJUVANT TREATMENT OF MALIGNANT MELANOMA
    Calabria, Caterina
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Blasi, Livio
    Stefano, Rosalba
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 88 - 89
  • [4] Intermediate dose interferon alfa 2b (IFN alfa 2b) in adiuvant treatment for malignant melanoma
    Agostara, B.
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, Agata
    Pepe, A.
    Rondello, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 59 - 60
  • [5] Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma
    Huerva, Valentin
    Cid-Bertomeu, Pau
    Espinet, Ramon
    Canto, Luisa M.
    OCULAR ONCOLOGY AND PATHOLOGY, 2022, 8 (02) : 88 - 92
  • [6] Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b):: Application of new reporter gene assay for IFN-α2b potency determinations
    Caserman, Simon
    Menart, Viktor
    Das, Rose Gaines
    Williams, Stella
    Meager, Anthony
    JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 319 (1-2) : 6 - 12
  • [7] Comparisons of Pharmacokinetic Profiles of High Dose Interferon-α2b (IFN) and peginterferon-α2b (PEG-IFN) in Melanoma Patients
    Xu, C.
    Daud, A. I.
    DeConti, R. C.
    Floren, L. C.
    Hwu, W. J.
    Guminsk, A.
    Sabesan, S.
    Batageli, E.
    Prasad, P.
    Yver, A.
    Sondak, V. K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1122 - 1122
  • [8] Interferon alpha 2b induced urticaria in a young women with a melanoma
    Lancrajan, I
    Bumbacea, R.
    Petrutescu, B.
    Giurcaneanu, C.
    ALLERGY, 2010, 65 : 241 - 241
  • [9] Health-related quality of life measures in melanoma patients receiving pulsed high-dose intravenous interferon alpha 2b (IFNα2b)
    Mohr, P.
    Hauschild, A.
    Trefzer, U.
    Neuber, K.
    Enk, A.
    Raas, K.
    Gogas, H.
    Kuechler, T.
    Weichenthal, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Is weekly PEG IFN alpha 2B with ribavirin therapy better than daily IFN alpha 2B with ribavirin therapy?
    Ahmed, U
    Ahmed, S
    Wright, H
    Nour, B
    Gurakar, A
    Schade, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S104 - S104
12345